News | May 06, 2026
Pfizer powers ahead in 2026 with strong Q1 results as pipeline momentum builds
The pharmaceutical giant reported $14.5 billion in revenue, up 5% year-over-year, and reaffirmed its full-year outlook
The pharmaceutical giant reported $14.5 billion in revenue, up 5% year-over-year, and reaffirmed its full-year outlook
The device is designed for early and accurate diagnosis of obstructive airway diseases such as COPD, and Asthma
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
The aim is to simplify and strengthen long-term control of airway disease through triple therapy in one device
New acetabular system enhances precision, stability and robotic compatibility in total hip arthroplasty
_256_384.jpg)
The approval makes Cipla’s product the first AB-rated generic therapeutic equivalent of Ventolin HFA
New appointments bring diagnostics and medtech expertise to strengthen healthcare delivery and policy engagement
As part of the partnership, Boehringer Ingelheim will provide access to its opnMe® platform, enabling broader scientific exchange and driving innovation-led research.
The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India
Extending production capabilities to the Americas helps reduce labor costs and inventory complexity for nutraceuticals and other industries while maintaining superior moisture control
Subscribe To Our Newsletter & Stay Updated
